JelloX Biotech Inc. (捷絡生物科技股份有限公司)

JelloX Biotech Inc. is a Taiwan-based biotech company specializing in 3D digital pathology imaging and AI-assisted diagnostic software. The company develops Metalite, a proprietary 3D pathology analysis software platform integrated with artificial intelligence modules designed to support precision medicine diagnostics. Metalite assists pathologists in evaluating clinical tissue specimen morphology variations and identifying tumor-targeted molecular distribution patterns, thereby enhancing cancer diagnosis accuracy and supporting new drug development workflows. The company positions itself as a pioneer in 3D intelligent pathology, leveraging innovative technology to enable precise medical diagnosis and treatment planning. JelloX markets its solutions internationally, collaborating with renowned hospitals and healthcare institutions to expand its global presence. The company emphasizes rigorous scientific validation and quality compliance as core values, with a commitment to building an integrated ecosystem of digital pathology and AI-enabled medical solutions. Services include 3D pathological image analysis and cancer cell detection support for clinical laboratories and research institutions.